214 related articles for article (PubMed ID: 23077524)
1. Antioxidant treatment promotes prostate epithelial proliferation in Nkx3.1 mutant mice.
Martinez EE; Anderson PD; Logan M; Abdulkadir SA
PLoS One; 2012; 7(10):e46792. PubMed ID: 23077524
[TBL] [Abstract][Full Text] [Related]
2. A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Martinez EE; Darke AK; Tangen CM; Goodman PJ; Fowke JH; Klein EA; Abdulkadir SA
Cancer Prev Res (Phila); 2014 Sep; 7(9):950-7. PubMed ID: 24894197
[TBL] [Abstract][Full Text] [Related]
3. Roles for Nkx3.1 in prostate development and cancer.
Bhatia-Gaur R; Donjacour AA; Sciavolino PJ; Kim M; Desai N; Young P; Norton CR; Gridley T; Cardiff RD; Cunha GR; Abate-Shen C; Shen MM
Genes Dev; 1999 Apr; 13(8):966-77. PubMed ID: 10215624
[TBL] [Abstract][Full Text] [Related]
4. Loss of glutathione peroxidase 3 induces ROS and contributes to prostatic hyperplasia in Nkx3.1 knockout mice.
Kim U; Kim CY; Lee JM; Ryu B; Kim J; Bang J; Ahn N; Park JH
Andrology; 2020 Sep; 8(5):1486-1493. PubMed ID: 32450005
[TBL] [Abstract][Full Text] [Related]
5. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis.
Song H; Zhang B; Watson MA; Humphrey PA; Lim H; Milbrandt J
Oncogene; 2009 Sep; 28(37):3307-19. PubMed ID: 19597465
[TBL] [Abstract][Full Text] [Related]
6. Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis.
Ouyang X; DeWeese TL; Nelson WG; Abate-Shen C
Cancer Res; 2005 Aug; 65(15):6773-9. PubMed ID: 16061659
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of the
Xie Q; Wang ZA
J Biol Chem; 2017 Aug; 292(33):13521-13530. PubMed ID: 28679531
[TBL] [Abstract][Full Text] [Related]
8. Cooperation of loss of
Le Magnen C; Virk RK; Dutta A; Kim JY; Panja S; Lopez-Bujanda ZA; Califano A; Drake CG; Mitrofanova A; Abate-Shen C
Dis Model Mech; 2018 Nov; 11(11):. PubMed ID: 30266798
[TBL] [Abstract][Full Text] [Related]
9. Genetic interaction between Tmprss2-ERG gene fusion and Nkx3.1-loss does not enhance prostate tumorigenesis in mouse models.
Linn DE; Bronson RT; Li Z
PLoS One; 2015; 10(3):e0120628. PubMed ID: 25780911
[TBL] [Abstract][Full Text] [Related]
10. Nkx3.1 functions as para-transcription factor to regulate gene expression and cell proliferation in non-cell autonomous manner.
Zhou J; Qin L; Tien JC; Gao L; Chen X; Wang F; Hsieh JT; Xu J
J Biol Chem; 2012 May; 287(21):17248-17256. PubMed ID: 22465996
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9-Mediated Point Mutation in
Bowen C; Shibata M; Zhang H; Bergren SK; Shen MM; Gelmann EP
Cancer Res; 2020 Nov; 80(21):4805-4814. PubMed ID: 32943441
[No Abstract] [Full Text] [Related]
12. MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.
Iwata T; Schultz D; Hicks J; Hubbard GK; Mutton LN; Lotan TL; Bethel C; Lotz MT; Yegnasubramanian S; Nelson WG; Dang CV; Xu M; Anele U; Koh CM; Bieberich CJ; De Marzo AM
PLoS One; 2010 Feb; 5(2):e9427. PubMed ID: 20195545
[TBL] [Abstract][Full Text] [Related]
13. Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia.
Abdulkadir SA; Magee JA; Peters TJ; Kaleem Z; Naughton CK; Humphrey PA; Milbrandt J
Mol Cell Biol; 2002 Mar; 22(5):1495-503. PubMed ID: 11839815
[TBL] [Abstract][Full Text] [Related]
14. RAMP1 is a direct NKX3.1 target gene up-regulated in prostate cancer that promotes tumorigenesis.
Logan M; Anderson PD; Saab ST; Hameed O; Abdulkadir SA
Am J Pathol; 2013 Sep; 183(3):951-63. PubMed ID: 23867798
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of prostate tumorigenesis: roles for transcription factors Nkx3.1 and Egr1.
Abdulkadir SA
Ann N Y Acad Sci; 2005 Nov; 1059():33-40. PubMed ID: 16382041
[TBL] [Abstract][Full Text] [Related]
16. Alterations of C-MYC, NKX3.1, and E-cadherin expression in canine prostate carcinogenesis.
Fonseca-Alves CE; Rodrigues MM; de Moura VM; Rogatto SR; Laufer-Amorim R
Microsc Res Tech; 2013 Dec; 76(12):1250-6. PubMed ID: 24030851
[TBL] [Abstract][Full Text] [Related]
17. Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression.
Bowen C; Ostrowski MC; Leone G; Gelmann EP
Cancer Res; 2019 Aug; 79(16):4124-4134. PubMed ID: 31213464
[No Abstract] [Full Text] [Related]
18. Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression.
Papachristodoulou A; Heidegger I; Virk RK; Di Bernardo M; Kim JY; Laplaca C; Picech F; Schäfer G; De Castro GJ; Hibshoosh H; Loda M; Klocker H; Rubin MA; Zheng T; Benson MC; McKiernan JM; Dutta A; Abate-Shen C
Eur Urol; 2024 Apr; 85(4):361-372. PubMed ID: 37659962
[TBL] [Abstract][Full Text] [Related]
19. Deletion of NKX3.1 via CRISPR/Cas9 Induces Prostatic Intraepithelial Neoplasia in C57BL/6 Mice.
Park JJ; Kim JE; Jeon Y; Lee MR; Choi JY; Song BR; Park JW; Kang MJ; Choi HJ; Bae SJ; Lee H; Kang BC; Hwang DY
Technol Cancer Res Treat; 2020; 19():1533033820964425. PubMed ID: 33094683
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of NKX3.1 in benign prostatic hyperplasia.
Irer B; Toylu A; Aslan G; Celebi I; Yorukoglu K; Atabey N
Urology; 2009 May; 73(5):1140-4. PubMed ID: 18597829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
